Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge

cnbc.com/2025/06/17/hong-kongs-regencell-bioscience-triples-in-latest-surge-for-a-speculative-stock.html

The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.

This story appeared on cnbc.com, 2025-06-17 11:53:35.
The Entire Business World on a Single Page. Free to Use →